4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
MediciNova, Inc. (MNOV) operates in the Biotechnology industry and is headquartered in La Jolla, United States with about 6 employees. Its market capitalization is roughly $66 million. In the fiscal year ended 2025-12-31, MNOV reported $0M in revenue and ($12M) in net income.
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.
Interactive charts & full statements → Open the MNOV valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $1M | $0M |
| Gross Profit | $0M | $0M | — | — |
| Operating Income (EBIT) | ($13M) | ($13M) | ($10M) | ($15M) |
| Net Income | ($12M) | ($11M) | ($9M) | ($14M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Gross Profit | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($3M) | ($3M) | ($3M) | ($4M) | ($3M) |
| Net Income | ($3M) | ($3M) | ($3M) | ($3M) | ($3M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $46M | $56M | $66M | $74M | — |
| Total Liabilities | $4M | $3M | $4M | $4M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MNOV viewer.
About TickerBase · Data methodology & sources